Bouvel Investment Partners LLC Sells 26,629 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Bouvel Investment Partners LLC trimmed its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 29.3% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 64,363 shares of the construction company’s stock after selling 26,629 shares during the period. Bouvel Investment Partners LLC’s holdings in Aspen Aerogels were worth $765,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Point72 Hong Kong Ltd bought a new stake in Aspen Aerogels in the second quarter worth $84,000. Quent Capital LLC bought a new position in Aspen Aerogels in the 3rd quarter worth about $118,000. Point72 DIFC Ltd bought a new position in Aspen Aerogels in the 2nd quarter worth about $121,000. Public Employees Retirement Association of Colorado bought a new stake in Aspen Aerogels during the 2nd quarter valued at about $145,000. Finally, nVerses Capital LLC raised its holdings in Aspen Aerogels by 45.0% in the third quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock worth $161,000 after buying an additional 1,800 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Price Performance

NYSE ASPN opened at $12.56 on Friday. The company’s 50 day moving average is $13.55 and its two-hundred day moving average is $20.31. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The stock has a market cap of $1.03 billion, a price-to-earnings ratio of 1,257.66 and a beta of 2.14. Aspen Aerogels, Inc. has a 12 month low of $10.75 and a 12 month high of $33.15.

Analyst Ratings Changes

ASPN has been the subject of several analyst reports. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a research report on Wednesday, November 13th. HC Wainwright restated a “buy” rating and issued a $30.00 price target on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Barclays reduced their price objective on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research report on Tuesday, November 12th. Canaccord Genuity Group cut their price target on Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating for the company in a research note on Thursday. Finally, Piper Sandler lowered their price objective on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Aspen Aerogels currently has an average rating of “Moderate Buy” and a consensus price target of $29.11.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.